Parexel

parexel.com · Durham, United States of America

Parexel is a global contract research organization that provides clinical research, regulatory, and consulting services to biopharmaceutical and medical device companies to support the development and commercialization of new therapies. The company manages clinical trials, data management, pharmacovigilance, and market access activities on an outsourced basis. Parexel generates revenue through long-term service contracts and project-based fees with life sciences clients worldwide.

Revenue
$1B+
Employees
5,001+
Founded
1982
Headquarters
Durham, United States of America

Parexel customers on Arbolus

Total customers 84 76 current · 8 former
Reviews growth 17 new reviews since Jun 2026

Customers who reviewed Parexel

Seniority of Parexel customers

Most people who reviewed Parexel hold Director roles (52%), followed by C-Suite (38%) and Manager (10%).

  • Director 52%
  • C-Suite 38%
  • Manager 10%

Customers sample

Other Leader Director NPS 9
Other Leader C-Suite NPS 5 Undecided
Other Analyst Director NPS 9 Undecided

Employer names and spend open in the full report, along with the other 80 customers.

What 83 Arbolus experts think of Parexel

Overall sentiment: Positive

Parexel displays a strong NPS performance with the majority of scores at 7-10, indicating solid promoter presence and generally positive user advocacy. Renewal intent is mixed: about half signal high likelihood to renew, but a significant cohort express uncertainty, particularly among mid to high spenders. Most participants are at a more-than-a-year implementation stage, reflecting deep engagement and operational integration. Expert themes praise regulatory expertise, global coverage, and secure automation, but highlight cost and occasional continuity concerns.

Everything 83 customers told us about Parexel.

Employer names, spend, renewal intent and every written answer behind the numbers on this page.

Sentiment

-7 Net Promoter Score, from 83 scored reviews
  • Promoters 22
  • Passives 33
  • Detractors 28

Praised

  • Mission-Critical Regulatory Support
  • Operational Efficiency and Speed
  • Unique Technology + Service Ecosystem
  • Advanced Automation

Criticised

  • Cost Concerns
  • Team Continuity
  • Need for Governance
  • Disruption from Autonomous AI

What Parexel customers say

Mission-Critical Regulatory Support

“I rely on Parexel when scalable global support and specialist regulatory expertise are needed across multiple markets, especially for complex programs.”

Legal Leader · Health Care · 10,000+ employees · EMEA

Operational Efficiency and Speed

“Parexel’s automation reduced programming cycle times and expedited regulatory submission generation by up to 60%, enabling us to meet regulatory milestones faster.”

Data Leader

Unique Technology + Service Ecosystem

“I recommend Parexel for its ability to fuse advanced automation with clinical services, ensuring compliance and solving the data accuracy challenges that generic solutions struggle with.”

Data Leader

Renewal intent

Plan to renew 23%
  • Will renew 16
  • Undecided 50
  • Not renewing 5

Plan to renew, by seniority

  • C-Suite 26% 27 answers
  • Director 22% 37 answers
  • Manager 17% 6 answers
  • Not specified 0% 1 answer
  • 7.8/10 Average score from customers who will renew
  • 7.1/10 Average score from undecided customers
  • 6.6/10 Average score from customers not renewing

Top alternatives

Most weighed by Parexel customers

Report

Nov 2026 84 + 1

For people who use Parexel

Do you use Parexel at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 83 customers of Parexel have already contributed

Takes a few minutes. Your identity stays anonymous.